Tessera Issues Positive Outlook
Tessera Technologies jumped sharply on positive guidance, but the firm continues to struggle to control expenses. Still, we’re keeping an eye on the company.
Exclusive Analysis for the Discerning Investor
Tessera Technologies jumped sharply on positive guidance, but the firm continues to struggle to control expenses. Still, we’re keeping an eye on the company.
The newest round of quantitative easing will have no end date, driving shares of commodity producers higher. We examine the impact.
Covidien provided strong fiscal year 2013 guidance, and the firm continues to return cash to shareholders at a healthy clip.
We’re huge fans of Apple and think the iPhone 5 will be a huge success.
Pier 1 Imports continues to experience strong results on the back of the housing recovery.
Pall reported decent fourth-quarter results, and it guided to strong earnings in fiscal 2013. We think shares are expensive.
TV shipments continue to plummet as the industry suffers from excess supply and weak demand. We take a look at the supply chain.
Gambling game supplier Shuffle Master (SHFL) reported weaker than expected third quarter results. Revenue increased 9% year-over-year to $63.4 million, several million short of consensus estimates. Earnings per share grew just 6% year-over-year to $0.18, a few cents short of consensus expectations. Though revenue growth was slightly disappointing, we were very encouraged to see recurring revenue advance 12% year-over-year to $30 million, marking its 15th consecutive quarter of expansion. Further, gross margins increased 100 basis points compared to last year to 63% thanks to more leases and higher average selling prices. Total utility revenue increased 8%, to $24.4 million, driven largely by strength in Macau and increased leases in the United States. The MD3 continues to spread thanks to superior card … Read more
Polypore reduced its second-half annual guidance as a result of weakness from GM’s Volt. We believe shares are fairly valued.
Semiconductor giant Texas Instruments narrowed its guidance range, but the company still sees weakness across the board. We aren’t interested in the shares.